Covered recipient · General Payments record
STACY NICOLE WATTS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$565.95
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.16 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $157.42 | 9 |
| ABBVIE INC. | $154.36 | 12 |
| Lilly USA, LLC | $154.25 | 10 |
| Sumitomo Pharma America, Inc. | $56.74 | 4 |
| PFIZER INC. | $16.17 | 1 |
| Acerta Pharma LLC | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.06 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385663 | CMS |
| ABBVIE INC. | $12.61 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385665 | CMS |
| ABBVIE INC. | $13.45 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385667 | CMS |
| ABBVIE INC. | $13.75 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385669 | CMS |
| ABBVIE INC. | $1.22 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385671 | CMS |
| ABBVIE INC. | $18.67 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385673 | CMS |
| ABBVIE INC. | $11.40 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385675 | CMS |
| ABBVIE INC. | $14.78 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385677 | CMS |
| ABBVIE INC. | $21.42 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385679 | CMS |
| ABBVIE INC. | $0.91 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385681 | CMS |
| ABBVIE INC. | $15.57 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385683 | CMS |
| ABBVIE INC. | $13.52 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108385685 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.22 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104720673 | CMS |
| Lilly USA, LLC | $16.78 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135966224 | CMS |
| Lilly USA, LLC | $15.00 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135944122 | CMS |
| Lilly USA, LLC | $14.60 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135867264 | CMS |
| Lilly USA, LLC | $17.18 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135944124 | CMS |
| Lilly USA, LLC | $13.57 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135953311 | CMS |
| Lilly USA, LLC | $23.46 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135912945 | CMS |
| Lilly USA, LLC | $12.69 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135953313 | CMS |
| Lilly USA, LLC | $10.74 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135966226 | CMS |
| Lilly USA, LLC | $17.05 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135891084 | CMS |
| Lilly USA, LLC | $13.18 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135867268 | CMS |
| Novo Nordisk Inc | $21.35 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100620602 | CMS |
| Novo Nordisk Inc | $15.92 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100280924 | CMS |
| Novo Nordisk Inc | $18.30 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497505 | CMS |
| Novo Nordisk Inc | $21.01 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100535425 | CMS |
| Novo Nordisk Inc | $20.41 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100596367 | CMS |
| Novo Nordisk Inc | $15.56 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100258400 | CMS |
| Novo Nordisk Inc | $14.52 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100279846 | CMS |
| Novo Nordisk Inc | $16.76 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100645793 | CMS |
| Novo Nordisk Inc | $13.59 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100526353 | CMS |
| PFIZER INC. | $16.17 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131996981 | CMS |
| Sumitomo Pharma America, Inc. | $14.18 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149002901 | CMS |
| Sumitomo Pharma America, Inc. | $13.42 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149002903 | CMS |
| Sumitomo Pharma America, Inc. | $14.94 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149002905 | CMS |
| Sumitomo Pharma America, Inc. | $14.20 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149002907 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.